Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond A Alvarez

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Antiviral Research|January 31, 2025
High HIV-1 viremia and low anti-Env antibody responses are associated with delayed treatment response to fostemsavir in highly treatment-experienced individualsSvenja Weiss, Raymond A Alvarez, Marisa Goff, et al.
Cell Reports|May 26, 2022
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomesJose L Garrido, Matías A Medina, Felipe Bravo, et al.
Elife|October 29, 2024
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progressionMatias A Medina, Francisco Fuentes-Villalobos, Claudio Quevedo, et al.
Frontiers in Immunology|May 23, 2024
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activitiesJéromine Klingler, Shreyas Kowdle, Juan C Bandres, et al.
JCI Insight|February 28, 2017
Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgGRaymond A Alvarez, Ana M Maestre, Kenneth Law, et al.
Frontiers in Immunology|June 22, 2026
Polyfunctional antibody signature defines protection in Andes hantavirus survivalFelipe Bravo, Tybbysay P Salinas, Camila Kossack, et al.
The Journal of Clinical Investigation|March 17, 2025
Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profilesSvenja Weiss, Hung-Mo Lin, Eric Acosta, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Antiviral Research|January 31, 2025
High HIV-1 viremia and low anti-Env antibody responses are associated with delayed treatment response to fostemsavir in highly treatment-experienced individualsSvenja Weiss, Raymond A Alvarez, Marisa Goff, et al.
Cell Reports|May 26, 2022
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomesJose L Garrido, Matías A Medina, Felipe Bravo, et al.
Elife|October 29, 2024
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progressionMatias A Medina, Francisco Fuentes-Villalobos, Claudio Quevedo, et al.
Frontiers in Immunology|May 23, 2024
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activitiesJéromine Klingler, Shreyas Kowdle, Juan C Bandres, et al.
JCI Insight|February 28, 2017
Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgGRaymond A Alvarez, Ana M Maestre, Kenneth Law, et al.
Frontiers in Immunology|June 22, 2026
Polyfunctional antibody signature defines protection in Andes hantavirus survivalFelipe Bravo, Tybbysay P Salinas, Camila Kossack, et al.
The Journal of Clinical Investigation|March 17, 2025
Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profilesSvenja Weiss, Hung-Mo Lin, Eric Acosta, et al.
Pageof 2